Emerging applications for zebrafish as a model organism to study oxidative mechanisms and their roles in inflammation and vascular accumulation of oxidized lipids

Free Radical Biology and Medicine

Volumn 53, Issue 7, 2012, Pages 1411-1420

  Fang, Longhou ^a   Miller, Yury I ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

F1luorescent reporter; HIF; Hydrogen peroxide; Lipid oxidation; NRF2; Oxidation specific antibody; Transgenic; Zebrafish

Indexed keywords

CAVEOLIN 1; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; CYCLOPENTENONE DERIVATIVE; DICHLORODIHYDROFLUORESCEIN DIACETATE; EPITOPE; EZETIMIBE; GREEN FLUORESCENT PROTEIN; HYDROGEN PEROXIDE; HYDROXAMIC ACID; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOCORTIN 2; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; PHOSPHOLIPASE A2; PROBUCOL; PROSTAGLANDIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; RECOMBINANT ANTIBODY; SIMVASTATIN; TRANSCRIPTION FACTOR NRF2; VON HIPPEL LINDAU PROTEIN;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; BODY TEMPERATURE; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; DISEASE COURSE; EXPERIMENTAL MODEL; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC CODE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IMMUNOASSAY; IN VIVO STUDY; INFLAMMATION; LARVA; LIPID OXIDATION; LIPID STORAGE; MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; TRANSGENIC ANIMAL; UBIQUITINATION; ZEBRA FISH;

ANIMALS; BLOOD VESSELS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROGEN PEROXIDE; HYPERCHOLESTEROLEMIA; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATION; LIPID METABOLISM; LIPIDS; MALONDIALDEHYDE; MOLECULAR IMAGING; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; ZEBRAFISH; ZEBRAFISH PROTEINS;

ANIMALIA; DANIO RERIO;

EID: 84865643057     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.08.004     Document Type: Review

References (121)

1. R.T. Peterson, and C.A. MacRae Systematic approaches to toxicology in the zebrafish Annu. Rev. Pharmacol. Toxicol. 52 2012 433 453
2. J.J. Dowling, S. Arbogast, J. Hur, D.D. Nelson, A. McEvoy, T. Waugh, I. Marty, J. Lunardi, S.V. Brooks, J.Y. Kuwada, and A. Ferreiro Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy Brain 135 2012 1115 1127
3. B. Shao, L. Zhu, M. Dong, J. Wang, J. Wang, H. Xie, Q. Zhang, Z. Du, and S. Zhu DNA damage and oxidative stress induced by endosulfan exposure in zebrafish (Danio rerio) Ecotoxicology 21 2012 1533 1540
4. Chen, Y.; Zeng, S.F.; Cao, Y.F. Oxidative stress response in zebrafish (Danio rerio) gill experimentally exposed to subchronic microcystin-LR. Environ. Monit. Assess. (in press).
5. K.H. Park, and K.H. Cho A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins Fish Shellfish Immunol 31 2011 904 910
6. K.H. Cho Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration J. Gerontol. A Biol. Sci. Med. Sci 66 2011 1274 1285
7. B. D'Autreaux, and M.B. Toledano ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis Nat. Rev. Mol. Cell. Biol. 8 2007 813 824
8. K. Schroder Isoform specific functions of Nox protein-derived reactive oxygen species in the vasculature Curr. Opin. Pharmacol 10 2010 122 126
9. K. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
10. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu. Rev. Physiol. 72 2010 219 246
11. K. Ley, Y.I. Miller, and C.C. Hedrick Monocyte and macrophage dynamics during atherogenesis Arterioscler. Thromb. Vasc. Biol. 31 2011 1506 1516
12. S. Tsimikas, and Y.I. Miller Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease Curr. Pharm. Des 17 2011 27 37
13. X. Meng, M.B. Noyes, L.J. Zhu, N.D. Lawson, and S.A. Wolfe Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases Nat. Biotech 26 2008 695 701
14. Y. Doyon, J.M. McCammon, J.C. Miller, F. Faraji, C. Ngo, G.E. Katibah, R. Amora, T.D. Hocking, L. Zhang, E.J. Rebar, P.D. Gregory, F.D. Urnov, and S.L. Amacher Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases Nat. Biotechnol. 26 2008 702 708
15. J.E. Foley, J.R. Yeh, M.L. Maeder, D. Reyon, J.D. Sander, R.T. Peterson, and J.K. Joung Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN) PLoS ONE 4 2009 e4348
16. J.D. Sander, E.J. Dahlborg, M.J. Goodwin, L. Cade, F. Zhang, D. Cifuentes, S.J. Curtin, J.S. Blackburn, S. Thibodeau-Beganny, Y. Qi, C.J. Pierick, E. Hoffman, M.L. Maeder, C. Khayter, D. Reyon, D. Dobbs, D.M. Langenau, R.M. Stupar, A.J. Giraldez, D.F. Voytas, R.T. Peterson, J.R. Yeh, and J.K. Joung Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA) Nat. Methods 8 2011 67 69
17. P. Huang, A. Xiao, M. Zhou, Z. Zhu, S. Lin, and B. Zhang Heritable gene targeting in zebrafish using customized TALENs Nat. Biotechnol. 29 2011 699 700
18. J.D. Sander, L. Cade, C. Khayter, D. Reyon, R.T. Peterson, J.K. Joung, and J.R. Yeh Targeted gene disruption in somatic zebrafish cells using engineered TALENs Nat. Biotechnol. 29 2011 697 698
19. P.J. Babin, C. Thisse, M. Durliat, M. Andre, M.A. Akimenko, and B. Thisse Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development Proc. Natl. Acad. Sci. USA 94 1997 8622 8627
20. M. Durliat, M. Andre, and P.J. Babin Conserved protein motifs and structural organization of a fish gene homologous to mammalian apolipoprotein E Eur. J. Biochem. 267 2000 549 559
21. A.H. Meijer, S.F. Gabby Krens, R. Medina, and I. He S.; Bitter, W.; Ewa Snaar-Jagalska, B.; Spaink, H. P. Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish Mol. Immunol. 40 2004 773 783
22. C. Jault, L. Pichon, and J. Chluba Toll-like receptor gene family and TIR-domain adapters in Danio rerio Mol. Immunol. 40 2004 759 771
23. S.H. Lam, H.L. Chua, Z. Gong, T.J. Lam, and Y.M. Sin Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study Dev. Comp. Immunol. 28 2004 9 28
24. S.Y. Ho, J.L. Thorpe, Y. Deng, E. Santana, R.A. DeRose, and S.A. Farber Lipid metabolism in zebrafish Methods Cell Biol. 76 2004 87 108
25. B.D. Crawford, and D.B. Pilgrim Ontogeny and regulation of matrix metalloproteinase activity in the zebrafish embryo by in vitro and in vivo zymography Dev. Biol 286 2005 405 414
26. A. Schlegel, and D.Y.R. Stainier Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae Biochemistry 45 2006 15179 15187
27. S.Y. Ho, K. Lorent, M. Pack, and S.A. Farber Zebrafish fat-free is required for intestinal lipid absorption and Golgi apparatus structure Cell Metab. 3 2006 289 300
28. A.M. van der Sar, O.W. Stockhammer, L.C. van der, and H.P. Spaink Bitter, W.; Meijer, A. H. MyD88 innate immune function in a zebrafish embryo infection model Infect. Immun. 74 2006 2436 2441
29. F. Arnault, J. Etienne, L. Noe, A. Raisonnier, D. Brault, J. Harney, M. Berry, C. Tse, C. Fromental-Ramain, J. Hamelin, and F. Galibert Human lipoprotein lipase last exon is not translated, in contrast to lower vertebrates J. Mol. Evol. 43 1996 109 115
30. M. Kobayashi, K. Itoh, T. Suzuki, H. Osanai, K. Nishikawa, Y. Katoh, Y. Takagi, and M. Yamamoto Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system Genes Cells 7 2002 807 820
31. A.R. Timme-Laragy, L.A. Van Tiem, E.A. Linney, and R.T. Di Giulio Antioxidant responses and NRF2 in synergistic developmental toxicity of PAHs in zebrafish Toxicol. Sci 109 2009 217 227
32. D.A. Rojas, D.A. Perez-Munizaga, L. Centanin, M. Antonelli, P. Wappner, M.L. Allende, and A.E. Reyes Cloning of hif-1alpha and hif-2alpha and mRNA expression pattern during development in zebrafish Gene Expression Patterns 7 2007 339 345
33. L.A. Van Tiem, and R.T. Di Giulio AHR2 knockdown prevents PAH-mediated cardiac toxicity and XRE- and ARE-associated gene induction in zebrafish (Danio rerio) Toxicol. Appl. Pharmacol. 254 2011 280 287
34. S.N. Greer, J.L. Metcalf, Y. Wang, and M. Ohh The updated biology of hypoxia-inducible factor EMBO J 31 2012 2448 2460
35. S.M. Yeligar, K. Machida, and V.K. Kalra Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1β and Nrf2 to attenuate inflammatory cytokine expression J. Biol. Chem. 285 2010 35359 35373
36. E. van Rooijen, E.E. Voest, I. Logister, J. Korving, T. Schwerte, S. Schulte-Merker, R.H. Giles, and F.J. van Eeden Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia Blood 113 2009 6449 6460
37. Santhakumar, K.; Judson, E.C.; Elks, P.M.; McKee, S.; Elworthy, S.; van Rooijen, E.; Walmsley, S.S.; Renshaw, S.; Cross, S.S.; van Eeden, F.J. A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis. Cancer Res. 72:4017-4027; 2012.
38. Y. Maeda, T. Suzuki, X. Pan, G. Chen, S. Pan, T. Bartman, and J.A. Whitsett CUL2 is required for the activity of hypoxia-inducible factor and vasculogenesis J. Biol. Chem. 283 2008 16084 16092
39. P.M. Elks, F.J. van Eeden, G. Dixon, X. Wang, C.C. Reyes-Aldasoro, P.W. Ingham, M.K.B. Whyte, S.R. Walmsley, and S.A. Renshaw Activation of hypoxia-inducible factor-1alpha (Hif-1alpha) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model Blood 118 2011 712 722
40. T. Nguyen, P. Nioi, and C.B. Pickett The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress J. Biol. Chem. 284 2009 13291 13295
41. A.R. Timme-Laragy, S.I. Karchner, D.G. Franks, M.J. Jenny, R.C. Harbeitner, J.V. Goldstone, A.G. McArthur, and M.E. Hahn Nrf2b, novel zebrafish paralog of oxidant-responsive transcription factor NF-E2-related factor 2 (NRF2) J. Biol. Chem. 287 2012 4609 4627
42. F. Ding, W.H. Song, J. Guo, M.L. Gao, and W.X. Hu Oxidative stress and structure-activity relationship in the zebrafish (Danio rerio) under exposure to paclobutrazol J. Environ. Sci. Health B 44 2009 44 50
43. C.T. Lin, W.C. Tseng, N.W. Hsiao, H.H. Chang, and C.F. Ken Characterization, molecular modelling and developmental expression of zebrafish manganese superoxide dismutase Fish Shellfish Immunol. 27 2009 318 324
44. G.S. Gerhard, E.J. Kauffman, and M.A. Grundy Molecular cloning and sequence analysis of the Danio rerio catalase gene Comp. Biochem. Physiol. B Biochem. Mol. Biol 127 2000 447 457
45. Y. Jin, X. Zhang, L. Shu, L. Chen, L. Sun, H. Qian, W. Liu, and Z. Fu Oxidative stress response and gene expression with atrazine exposure in adult female zebrafish (Danio rerio) Chemosphere 78 2010 846 852
46. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity N. Engl. J. Med. 320 1989 915 924
47. J.L. Witztum, and D. Steinberg The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med 11 2004 93 102
48. Y.I. Miller, S.-H. Choi, P. Wiesner, L. Fang, R. Harkewicz, K. Hartvigsen, A. Boullier, A. Gonen, C.J. Diehl, X. Que, E. Montano, P.X. Shaw, S. Tsimikas, C.J. Binder, and J.L. Witztum Oxidation-specific epitopes are danger associated molecular patterns recognized by pattern recognition receptors of innate immunity Circ. Res. 108 2011 235 248
49. J.L. Anderson, J.D. Carten, and S.A. Farber Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol Methods Cell Biol. 101 2011 111 141
50. P.J. Babin, and J.M. Vernier Plasma lipoproteins in fish J. Lipid Res. 30 1989 467 489
51. K. Stoletov, L. Fang, S.H. Choi, K. Hartvigsen, L.F. Hansen, C. Hall, J. Pattison, J. Juliano, E.R. Miller, and F. Almazan Crosier, P.; Witztum, J. L.; Klemke, R. L.; Miller, Y. I. Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish Circ. Res. 104 2009 952 960
52. G. Poupard, M. Andre, M. Durliat, C. Ballagny, G. Boeuf, and P.J. Babin Apolipoprotein E gene expression correlates with endogenous lipid nutrition and yolk syncytial layer lipoprotein synthesis during fish development Cell Tissue Res. 300 2000 251 261
53. E. Marza, C. Barthe, M. Andre, L. Villeneuve, C. Helou, and P.J. Babin Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit Dev. Dyn. 232 2005 506 518
54. S. Jin, and K.H. Cho Water extracts of cinnamon and clove exhibit potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish Food Chem. Toxicol 49 2011 1521 1529
55. J.Y. Kim, J. Seo, and K.H. Cho Aspartame-fed zebrafish exhibit acute deaths with swimming defects and saccharin-fed zebrafish have elevation of cholesteryl ester transfer protein activity in hypercholesterolemia Food Chem. Toxicol 49 2011 2899 2905
56. E.J. Smart, R.A. De Rose, and S.A. Farber Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport Proc. Natl. Acad. Sci. USA 101 2004 3450 3455
57. J.D. Clifton, E. Lucumi, M.C. Myers, A. Napper, K. Hama, S.A. Farber, A.B. Smith I.I.I., D.M. Huryn, S.L. Diamond, and M. Pack Identification of novel inhibitors of dietary lipid absorption using zebrafish PLoS ONE 5 2010 e12386
58. J.S. Baek, L. Fang, A.C. Li, and Y.I. Miller Ezetimibe and simvastatin reduce cholesterol levels in zebrafish larvae fed a high-cholesterol diet Cholesterol 2012 564705 2012
59. A.C. Hermann, P.J. Millard, S.L. Blake, and C.H. Kim Development of a respiratory burst assay using zebrafish kidneys and embryos J. Immunol. Methods 292 2004 119 129
60. S.L. Walker, J. Ariga, J.R. Mathias, V. Coothankandaswamy, X. Xie, M. Distel, R.W. Koster, M.J. Parsons, K.N. Bhalla, M.T. Saxena, and J.S. Mumm Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafish PLoS ONE 7 2012 e29916
61. J. Shepherd, S.A. Hilderbrand, P. Waterman, J.W. Heinecke, R. Weissleder, and P. Libby A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages Chem. Biol. 14 2007 1221 1231
62. Z.N. Sun, F.Q. Liu, Y. Chen, P.K.H. Tam, and D. Yang A highly specific BODIPY-based fluorescent probe for the detection of hypochlorous acid Org. Lett. 10 2008 2171 2174
63. Y. Koide, Y. Urano, K. Hanaoka, T. Terai, and T. Nagano Development of an Si-rhodamine-based far-red to near-infrared fluorescence probe selective for hypochlorous acid and its applications for biological imaging J. Am. Chem. Soc 133 2011 5680 5682
64. Y.K. Yang, H.J. Cho, J. Lee, I. Shin, and J. Tae A rhodamine-hydroxamic acid-based fluorescent probe for hypochlorous acid and its applications to biological imagings Org. Lett. 11 2009 859 861
65. X. Cheng, H. Jia, T. Long, J. Feng, J. Qin, and Z.A. Li turn-on fluorescent probe for hypochlorous acid: convenient synthesis, good sensing performance, and a new design strategy by the removal of C=N isomerization Chem. Commun. (Cambridge) 47 2011 11978 11980
66. Y. Zhou, J.Y. Li, K.H. Chu, K. Liu, C. Yao, and J.Y. Li Fluorescence turn-on detection of hypochlorous acid via HOCl-promoted dihydrofluorescein- ether oxidation and its application in vivo Chem. Commun. (Cambridge) 48 2012 4677 4679
67. V.V. Belousov, A.F. Fradkov, K.A. Lukyanov, D.B. Staroverov, K.S. Shakhbazov, A.V. Terskikh, and S. Lukyanov Genetically encoded fluorescent indicator for intracellular hydrogen peroxide Nat. Methods 3 2006 281 286
68. 2 with expanded dynamic range Bioorg. Med. Chem. 19 2011 1079 1084
69. P. Niethammer, C. Grabher, A.T. Look, and T.J. Mitchison A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish Nature 459 2009 996 999
70. S.K. Yoo, T.W. Starnes, Q. Deng, and A. Huttenlocher Lyn is a redox sensor that mediates leukocyte wound attraction in vivo Nature 480 2011 109 112
71. T. Suzuki, Y. Takagi, H. Osanai, L. Li, M. Takeuchi, Y. Katoh, M. Kobayashi, and M. Yamamoto Pi class glutathione S-transferase genes are regulated by Nrf 2 through an evolutionarily conserved regulatory element in zebrafish Biochem. J. 388 2005 65 73
72. T. Tsujita, L. Li, H. Nakajima, N. Iwamoto, Y. Nakajima-Takagi, K. Ohashi, K. Kawakami, Y. Kumagai, B.A. Freeman, M. Yamamoto, and M. Kobayashi Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish Genes Cells 16 2011 46 57
73. B.W. Kusik, M.J. Carvan, and I.I.I. Udvadia A. J. Detection of mercury in aquatic environments using EPRE reporter zebrafish Mar. Biotechnol. (New York) 10 2008 750 757
74. C.K. Glass, and J.L. Witztum Atherosclerosis: the road ahead Cell 104 2001 503 516
75. W. Palinski, S. Horkko, E. Miller, U.P. Steinbrecher, H.C. Powell, L.K. Curtiss, and J.L. Witztum Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma J. Clin. Invest. 98 1996 800 814
76. S. Horkko, E. Miller, D.W. Branch, W. Palinski, and J.L. Witztum The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins) Proc. Natl. Acad. Sci. USA 94 1997 10356 10361
77. S. Hörkkö, D.A. Bird, E. Miller, H. Itabe, N. Leitinger, and G. Subbanagounder Berliner, J. A.; Friedman, P.; Dennis, E. A.; Curtiss, L. K.; Palinski, W.; Witztum, J. L. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins J. Clin. Invest. 103 1999 117 128
78. P.X. Shaw, S. Hörkkö, M.K. Chang, L.K. Curtiss, W. Palinski, G.J. Silverman, and J.L. Witztum Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity J. Clin. Invest. 105 2000 1731 1740
79. P.X. Shaw, S. Hörkkö, S. Tsimikas, M.K. Chang, W. Palinski, G.J. Silverman, P.P. Chen, and J.L. Witztum Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo Arterioscler. Thromb. Vasc. Biol. 21 2001 1333 1339
80. C.J. Binder, P.X. Shaw, M.K. Chang, A. Boullier, K. Hartvigsen, S. Horkko, Y.I. Miller, D.A. Woelkers, M. Corr, and J.L. Witztum The immune system and atherogenesis: the role of natural antibodies in atherogenesis J. Lipid Res. 46 2005 1353 1363
81. A. Tuominen, Y.I. Miller, L.F. Hansen, Y.A. Kesaniemi, J.L. Witztum, and S. Horkko A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions Arterioscler. Thromb. Vasc. Biol. 26 2006 2096 2102
82. S. Tsimikas, C. Bergmark, R.W. Beyer, R. Patel, J. Pattison, E. Miller, J. Juliano, and J.L. Witztum Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes J. Am. Coll. Cardiol. 41 2003 360 370
83. S. Tsimikas, H.K. Lau, K.R. Han, B. Shortal, E.R. Miller, A. Segev, L.K. Curtiss, J.L. Witztum, and B.H. Strauss Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein Circulation 109 2004 3164 3170
84. S. Tsimikas, E.S. Brilakis, E.R. Miller, J.P. McConnell, R.J. Lennon, K.S. Kornman, J.L. Witztum, and P.B. Berger Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease N. Engl. J. Med. 353 2005 46 57
85. S. Tsimikas Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease Am. J. Cardiol. 98 2006 S9 S17
86. M. Mayr, S. Kiechl, S. Tsimikas, E. Miller, J. Sheldon, J. Willeit, J.L. Witztum, and Q. Xu Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study J. Am. Coll. Cardiol. 47 2006 2436 2443
87. S. Kiechl, J. Willeit, M. Mayr, B. Viehweider, M. Oberhollenzer, F. Kronenberg, C.J. Wiedermann, S. Oberthaler, Q. Xu, J.L. Witztum, and S. Tsimikas Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck Study Arterioscler. Thromb. Vasc. Biol. 27 2007 1788 1795
88. S. Tsimikas, E.S. Brilakis, R.J. Lennon, E.R. Miller, J.L. Witztum, J.P. McConnell, K.S. Kornman, and P.B. Berger Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events J. Lipid Res. 48 2007 425 433
89. A. Burke, N. Cresswell, F. Kolodgie, R. Virmani, and S. Tsimikas Increased expression of oxidation-specific epitopes and Lp(a) reflect unstable plaques in human coronary arteries J. Am. Coll. Cardiol. 49 2008 A299
90. S. Tsimikas, A. Miyanohara, K. Hartvigsen, E. Merki, P.X. Shaw, M.Y. Chou, J. Pattison, M. Torzewski, J. Sollors, T. Friedmann, C. Lai, K. Hammond, G.S. Getz, C.A. Reardon, A.C. Li, C. Banka, and J.L. Witztum Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression J. Am. Coll. Cardiol. 58 2011 1715 1727
91. K. Arai, A. Orsoni, Z. Mallat, A. Tedgui, J.L. Witztum, E. Bruckert, A.D. Tselepis, M.J. Chapman, and S. Tsimikas Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia J. Lipid Res. 53 2012 1670 1678
92. G. Leibundgut, K. Arai, A. Orsoni, H. Yin, C. Scipione, E.R. Miller, M.L. Koschinsky, M.J. Chapman, J.L. Witztum, and S. Tsimikas Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction J. Am. Coll. Cardiol. 59 2012 1426 1437
93. A. Taleb, and S. Tsimikas Lipoprotein oxidation biomarkers for cardiovascular risk: what does the future hold? Expert Rev. Cardiovasc. Ther. 10 2012 399 402
94. S.K. Ryu, Z. Mallat, J. Benessiano, A. Tedgui, A.G. Olsson, W. Bao, G.G. Schwartz, and S. Tsimikas Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes Circulation 125 2012 757 766
95. P. Fefer, S. Tsimikas, A. Segev, J. Sparkes, F. Otsuma, F. Kolodgie, R. Virmani, J. Juliano, T. Charron, and B.H. Strauss The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization Cardiovasc. Revasc. Med 13 2012 11 19
96. L. Fang, S.R. Green, J.S. Baek, S.H. Lee, F. Ellett, E. Deer, G.J. Lieschke, J.L. Witztum, S. Tsimikas, and Y.I. Miller In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish J. Clin. Invest. 121 2011 4861 4869
97. L. Fang, R. Harkewicz, K. Hartvigsen, P. Wiesner, S.H. Choi, F. Almazan, J. Pattison, E. Deer, T. Sayaphupha, E.A. Dennis, J.L. Witztum, S. Tsimikas, and Y.I. Miller Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high-cholesterol diet: macrophage binding and activation J. Biol. Chem. 285 2010 32343 32351
98. R. Harkewicz, K. Hartvigsen, F. Almazan, E.A. Dennis, J.L. Witztum, and Y.I. Miller Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized LDL J. Biol. Chem. 283 2008 10241 10251
99. P.M. Hutchins, E.E. Moore, and R.C. Murphy Electrospray tandem mass spectrometry reveals extensive and non-specific oxidation of cholesterol esters in human peripheral vascular lesions J. Lipid Res 52 2011 2070 2083
100. S.-H. Choi, R. Harkewicz, J.H. Lee, A. Boullier, F. Almazan, A.C. Li, J.L. Witztum, Y.S. Bae, and Y.I. Miller Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake Circ. Res. 104 2009 1355 1363
101. Y.I. Miller, S.H. Choi, L. Fang, and R. Harkewicz Toll-like receptor-4 and lipoprotein accumulation in macrophages Trends Cardiovasc. Med 7 2009 227 232
102. J. Huber, H. Boechzelt, B. Karten, M. Surboeck, V.N. Bochkov, B.R. Binder, W. Sattler, and N. Leitinger Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway Arterioscler. Thromb. Vasc. Biol. 22 2002 581 586
103. G. Subbanagounder, J.W. Wong, H. Lee, K.F. Faull, E. Miller, and J.L. Witztum Berliner, J. A. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis: formation of these oxidized phospholipids in response to interleukin-1beta J. Biol. Chem. 277 2002 7271 7281
104. A. Boullier, P. Friedman, R. Harkewicz, K. Hartvigsen, S.R. Green, F. Almazan, E.A. Dennis, D. Steinberg, J.L. Witztum, and O. Quehenberger Phosphocholine as a pattern recognition ligand for CD36 J. Lipid Res. 46 2005 969 976
105. Berliner J.A. Watson A. D. A role for oxidized phospholipids in atherosclerosis N. Engl. J. Med. 353 2005 9 11
106. S. Lee, N.M. Gharavi, H. Honda, I. Chang, B. Kim, N. Jen, R. Li, and A. Zimman Berliner, J. A. A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids Free Radic. Biol. Med. 47 2009 145 151
107. O.A. Cherepanova, N.A. Pidkovka, O.F. Sarmento, T. Yoshida, Q. Gan, E. Adiguzel, and M.P. Bendeck Berliner, J.; Leitinger, N.; Owens, G. K. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration Circ. Res. 104 2009 609 618
108. V.N. Bochkov, D. Mechtcheriakova, M. Lucerna, J. Huber, R. Malli, W.F. Graier, E. Hofer, B.R. Binder, and N. Leitinger Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca/NFAT Blood 99 2002 199 206
109. A. Kadl, A.K. Meher, P.R. Sharma, M.Y. Lee, A.C. Doran, S.R. Johnstone, M.R. Elliott, F. Gruber, J. Han, W. Chen, T. Kensler, K.S. Ravichandran, B.E. Isakson, B.R. Wamhoff, and N. Leitinger Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 Circ. Res. 107 2010 737 746
110. J.B. Shaklee, J.A. Christiansen, B.D. Sidell, C.L. Prosser, and G.S. Whitt Molecular aspects of temperature acclimation in fish: contributions of changes in enzyme activities and isozyme patterns to metabolic reorganization in the green sunfish J. Exp. Zool. 201 1977 1 20
111. Y.C. Tseng, R.D. Chen, M. Lucassen, M.M. Schmidt, R. Dringen, D. Abele, and P.P. Hwang Exploring uncoupling proteins and antioxidant mechanisms under acute cold exposure in brains of fish PLoS ONE 6 2011 e18180
112. A.R. Cossins, P.A. Murray, A.Y. Gracey, J. Logue, S. Polley, M. Caddick, S. Brooks, T. Postle, and N. Maclean The role of desaturases in cold-induced lipid restructuring Biochem. Soc. Trans. 30 2002 1082 1086
113. J.R. Hazel Thermal adaptation in biological membranes: is homeoviscous adaptation the explanation? Annu. Rev. Physiol. 57 1995 19 42
114. K.C. Briley-Saebo, T.H. Nguyen, A.M. Saeboe, Y.S. Cho, S.K. Ryu, E.R. Volkova, S. Dickson, G. Leibundgut, P. Wiesner, S. Green, F. Casanada, Y.I. Miller, W. Shaw, J.L. Witztum, Z.A. Fayad, and S. Tsimikas In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes J. Am. Coll. Cardiol. 59 2012 616 626
115. S. Tsimikas, B.P. Shortal, J.L. Witztum, and W. Palinski In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression Arterioscler. Thromb. Vasc. Biol 20 2000 689 697
116. S. Parthasarathy, S.G. Young, J.L. Witztum, R.C. Pittman, and D. Steinberg Probucol inhibits oxidative modification of low density lipoprotein J. Clin. Invest. 77 1986 641 644
117. T.E. Carew, D.C. Schwenke, and D. Steinberg Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit Proc. Natl. Acad. Sci. USA 84 1987 7725 7729
118. J.S. Kirkwood, K.M. Lebold, C.L. Miranda, C.L. Wright, G.W. Miller, R.L. Tanguay, C.L. Barton, M.G. Traber, and J.F. Stevens Vitamin C deficiency activates the purine nucleotide cycle in zebrafish J. Biol. Chem. 287 2012 3833 3841
119. K.M. Lebold, D.B. Jump, G.W. Miller, C.L. Wright, E.M. Labut, C.L. Barton, R.L. Tanguay, and M.G. Traber Vitamin E deficiency decreases long-chain PUFA in zebrafish (Danio rerio) J. Nutr. 141 2011 2113 2118
120. W. Palinski, E. Miller, and J.L. Witztum Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis Proc. Natl. Acad. Sci. USA 92 1995 821 825
121. S. Freigang, S. Horkko, E. Miller, J.L. Witztum, and W. Palinski immunization of LDL receptor-deficient mice with homologous malondialdehyde- modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes Arterioscler. Thromb. Vasc. Biol 18 1998 1972 1982